The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients
- PMID: 32940881
- PMCID: PMC9205804
- DOI: 10.1007/s13187-020-01867-2
The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients
Abstract
Different patients want to take different roles in the treatment decision-making process; these roles can be classified as passive, collaborative, and active. The aim of this study was to investigate the correlation between decision-making preferences among patients with prostate cancer and personal, disease-related, and structural factors. In four survey studies, we asked 7169 prostate cancer patients about their decision-making preferences using the Control Preferences Scale (CPS) and collected clinical, psychological, and quality-of-life measures. Most patients (62.2%) preferred collaborative decision-making, while 2322 (32.4%) preferred an active role, and only 391 (5.5%) preferred a passive role. Age (p < 0.001), data collection mode (p < 0.001), peer-to-peer support (p = 0.018), treatment status (p < 0.001), performed or planned radical prostatectomy (p < 0.001), metastatic disease (p = 0.001), and quality of life (p < 0.001) showed significant associations with patients' preferred decision-making roles. Oncologic risk group, anxiety, and depression were not significant in the model. In particular, younger prostate cancer patients with higher quality of life completing an online survey want to play a more active role in treatment decision-making. Before treatment has started, patients tend to prefer collaborative decision-making. Few prostate cancer patients in Germany prefer a passive role. These patients are mostly older patients, patients with a metastatic disease, and patients who have opted for prostatectomy. Whether this finding reflects a generational effect or a tendency by age group and disease phase should be investigated. Further research is also needed to describe the causalities of these relationships. The CPS offers valuable information for personal counselling and should be applied in clinical routine. In a large group of patients with prostate cancer, we found that there is a strong desire for joint decision-making with the physician before the actual treatment. Especially younger men, men with active online behaviour, and men with a high quality of life want to be actively involved in therapy decision-making processes.
Keywords: Health services research; Prostate cancer; Treatment decision-making.
© 2020. The Author(s).
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Preferred and perceived participation roles of oncological patients in medical decision-making: Results of a survey among users of the German Cancer Information Service.Z Evid Fortbild Qual Gesundhwes. 2022 Aug;172:40-48. doi: 10.1016/j.zefq.2022.04.026. Epub 2022 Jun 24. Z Evid Fortbild Qual Gesundhwes. 2022. PMID: 35753947
-
Information and decision-making preferences of men with prostate cancer.Oncol Nurs Forum. 1995 Oct;22(9):1401-8. Oncol Nurs Forum. 1995. PMID: 8539181
-
Factors Affecting Satisfaction with the Decision-Making Process and Decision Regret for Men with a New Diagnosis of Prostate Cancer.Am J Mens Health. 2021 Jul-Aug;15(4):15579883211026812. doi: 10.1177/15579883211026812. Am J Mens Health. 2021. PMID: 34261353 Free PMC article.
-
Current decision-making in prostate cancer therapy.Curr Opin Urol. 2008 May;18(3):275-8. doi: 10.1097/MOU.0b013e3282fba5f2. Curr Opin Urol. 2008. PMID: 18382237 Review.
-
The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research.World J Urol. 2008 Oct;26(5):469-74. doi: 10.1007/s00345-008-0279-7. Epub 2008 Jun 12. World J Urol. 2008. PMID: 18548254 Review.
Cited by
-
Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey.Cancer Med. 2023 Mar;12(5):6040-6055. doi: 10.1002/cam4.5313. Epub 2022 Oct 13. Cancer Med. 2023. PMID: 36226867 Free PMC article.
-
Decision-Making Preferences among Advanced Cancer Patients in a Palliative Setting in Jordan.Int J Environ Res Public Health. 2023 Apr 18;20(8):5550. doi: 10.3390/ijerph20085550. Int J Environ Res Public Health. 2023. PMID: 37107832 Free PMC article.
-
Patient engagement in designing and publishing research in prostate cancer: a scoping review.Future Oncol. 2024;20(35):2779-2790. doi: 10.2217/fon-2023-0543. Epub 2024 Apr 4. Future Oncol. 2024. PMID: 38573132 Free PMC article.
-
Different patients, different preferences: A multicenter assessment of patients' personality traits and anxiety in shared decision making.Cancer Med. 2022 Aug;11(15):2999-3008. doi: 10.1002/cam4.4667. Epub 2022 Mar 24. Cancer Med. 2022. PMID: 35322925 Free PMC article.
-
[Comparison of hospital rating websites among each other and with data from hospital quality reports and quality assurance based on routine data].Urologie. 2024 May;63(5):474-481. doi: 10.1007/s00120-023-02263-6. Epub 2024 Jan 24. Urologie. 2024. PMID: 38265488 Free PMC article. German.
References
-
- Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res. 1997;29(3):21–43. - PubMed
-
- Cuypers M, Lamers RED, de Vries M, Husson O, Kil PJM, van de Poll-Franse LV. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: results from the PROFILES registry. Urol Oncol. 2016;34(11):482 e411–482 e418. doi: 10.1016/j.urolonc.2016.06.015. - DOI - PubMed
-
- van Stam MA, Pieterse AH, van der Poel HG, Bosch J, Tillier C, Horenblas S, Aaronson NK. Shared decision-making in prostate cancer care: encouraging every patient to be actively involved in decision-making, or ensuring patients’ preferred level of involvement? J Urol. 2018;200:582–589. doi: 10.1016/j.juro.2018.02.3091. - DOI - PubMed
-
- Jayadevappa R, Chhatre S, Gallo JJ, Wittink M, Morales KH, Lee DI, Guzzo TJ, Vapiwala N, Wong Y-N, Newman DK. Patient-centered preference assessment to improve satisfaction with care among patients with localized prostate cancer: a randomized controlled trial. J Clin Oncol. 2019;37(12):964–973. doi: 10.1200/JCO.18.01091. - DOI - PubMed
-
- Baunacke M, Schmidt M-L, Groeben C, Borkowetz A, Thomas C, Koch R, Chun FK, Ihrig A, Weissbach L, Huber J (2019) Decision regret after radical prostatectomy does not depend upon surgical approach: 6-year follow-up of a large German cohort undergoing routine care. J Urol. 10.1097/JU.0000000000000541 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical